EACPT Congress of the European Association for Clinical Pharmacology and TherapeuticsEdinburgh, Scotland 12 - 15th July 2009

Monday

Julio Benitez - Drug discovery in the 'post-genomic era'

Adam Cohen - Early drug studies in man - what have we learned from TGN1412?

John Cockroft - Vascular stiffness - a key factor in hypertension

Stephane Laurent - What drugs should be using to treat hypertension

Laszlo Vecsei - Parkinson's disease: will therapy move beyond dopamine receptor agonists?

Gordon Murray - New approaches to clinical trial design and analysis

Patrick Vallance - The interface between clinical pharmacology in academia and industry

Hans-Georg Eichler - EMEA: regulating medicines in Europe

Alasdair Breckenridge - Risk management in drug regulation

Paul Durrington - Raising HDL and other new approaches

Soren Sindrup - Recent advances in the management of neuropathic pain

Maria Adele Giamberardi - Controlling pain in the post-operative setting

Baptist Gallwitz - Novel therapeutic strategies for type 2 diabetes

Emilio Perucca - New drug developments in epilepsy

Morris Brown - Prediction of antihypertensive response - phenotype?

Mark Caulfield - Prediction of antihypertensive response - genotype?

Ian Wilkinson - What response - brachial artery or aorta?